• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

SARS-CoV-2 RNA Frequently Found in Blood Donor Plasma is Not Infectious

September 7, 2022

Although no cases of SARS-CoV-2 transfusion-transmission have been reported worldwide, RNA is detected in 15% to 90% of patients with critical COVID-19 and 2% to 13% of individuals with mild COVID-19 symptoms.  A study recently published in The Journal of Clinical Investigation adds to the growing body of evidence that the risk of transfusion-transmission is very low.  From January 2020 through July 2021, four major blood collection centers (representing approximately 50% of the U.S. blood supply) investigated infectivity of 2,250 blood samples collected from individuals who self-reported post-donation COVID-19 infections and/or symptoms.  Overall, 196 (8.7%) were RNA positive for SARS-CoV-2.  One percent of samples were positive starting in March 2020; positivity peaked at 9% in September 2020 and 15% in March 2021, and fell to 4% in April 2021 after the introduction of widespread vaccination.  The median SARS-CoV-2 viral load was estimated to be very low—6 gEq/mL— with 90% of samples having an estimated viral load of 18 gEq/mL or lower. Both cell culture and mouse models of infection found that viral loads needed to be multiple log-folds higher to be infectious via blood transfusions.  These results suggest that SARS-CoV-2 is not transfusion transmissible and support the policy of not testing blood products for SARS-CoV-2.

Reference:

Saá, P, Fink RV, Bakkour S, Jin J, et al.  Frequent detection but lack of infectivity of SARS-CoV-2 RNA in presymptomatic, infected blood donor plasma.  The Journal of Clinical Investigation 2022; 132(17); e159876.

Filed Under

  • News
  • Transfusion Transmitted Infections

Recommended

  • Scientists Design a Bioreactor to Produce Platelets In Vitro

  • Intravenous Immunoglobulin Treatment for Patients with Heparin-Induced Thrombocytopenia Patients Unresponsive to Standard Treatment

  • Blood Donation Intervals Should Be Extended to 180 Days To Avoid Iron Deficiency

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Plasma Equivalent to Clotting Factor Concentrates for Initial Resuscitation of Patients with Severe Trauma

  • Personalized Prediction Model of Prophylactic Platelet Transfusions for Preterm Infants

  • Caffeine in Donor Blood Reduces Quality of Stored RBCs

  • Ferritin Levels Needed to Assess Hemoglobin Recovery after Blood Donation

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley